WIBA-AWARDS
26.5.2024 01:09:34 CEST | Business Wire | Press release
The sixth annual WIBA Awards for social media personalities on a mission to change the world took place on May 24th, 2024, at the iconic Hotel Martinez during the Cannes Film Festival. The event gathered hundreds of top global content creators responsible for the year’s most viral moments. The evening featured a cocktail reception, a Gala Dinner, and the Awards ceremony with a special performance by Sonique.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240525509294/en/
WIBA 2024 Winners (Photo: Business Wire)
The event awarded international celebrities and extraordinary personalities such as Coco Rocha, Lena Mahfouf (Situations), Alexandre Maras, Hyram, Sasha Ray and others. The Grand Prix WIBA title 2024 assigned to Burak Ozdemir, Turkish chef and restaurateur with over 129M followers on social media.
WIBA Awards were overseen by the World Influencers Association (WIBA) based in Monaco. It was the first and the only international award honoring the work of social media personalities across multiple categories.
WIBA Awards title holders are the top world influencers, such as Maye Musk, Richard Orlinski, Khaby Lame, Nusret Gökçe, Nikkie Tutorials, Gianluca Vacchi, Foodgod, Kat Graham, Kelly Rutherford, Ellen Von Unwerth and others.
WIBA Awards event highlighted the most followed social causes, empowered diverse influencers' voices, encouraged collaboration, and fostered a sense of a global community of peers. The typical instant reach of a WIBA Awards ballroom was over 200 million impressions.
WIBA 2024 Titles Holders 2024
Burak Özdemir: Grand Prix
Coco Rocha: Fashion Model Business Icon & Women Empowerment Advocate
Lena Situations: Motivation & Encouragement Lifestyle Influencer
Alexandre Maras: Most Influential Journalist in Social Media 2024
Hyram: Best Influential Skincare Expert
Mohamed Cheikh: French Contest Winners
Reem Khabbazeh: Most Influential Social Personality of Middle East
Lee Levi: Influential Actress in Social Media
Maxim Ivanchuk: Best Aesthetic Medicine Influencer
Esteriore Brothers: Best Entertainment Influencers
Max Mariola: Best Food Influencer
Sasha Ray: Fashion Lifestyle Influencer
Jeff Hamilton: Influential Celebrity Fashion Artist
Pietro Checchi: New Name of Italian Tiktok
Marcello D’Onofrio: Empowerment Celebrities Management Leader
Nadine Mirada: European Model Influencer
Daniel Asante: Social Media Model Influencer
Alex & Tom : Best Education Influencers
Elena Hazinah : Best Beauty Influencer
Angelina Usanova: Social Activity & Philanthropy Influencer
Francine Ehlke: Best Latin America Influencer
Youmna Khoury: Influential Beauty Business Leader
Urvashi Rautela: Influential Indian Star
PHOTOS: https://www.picdrop.com/gettyimagesit/6VAkztDsX3
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240525509294/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock20.4.2026 01:07:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company’s common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling any shares of its common stock in the offering. The Selling Stockholder will receive all of the proceeds from the offering. Maxim Group LLC is acting as the sole book-running manager and Roth Capital Partners is acting as the co-manager for the offering. The offering is being made pursuant to the Com
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms20.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, will unveil a new ‘all-in-one’ powertrain at Beijing Auto Show 2026: the X-Range C15 Direct Drive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419640202/en/ Left-facing view of the HORSE X-Range C15 Direct Drive The ultra-compact X-Range C15 Direct Drive integrates a full hybrid powertrain – including a 4-cylinder engine, transmission, power electronics, and an electric motor – into a single compact unit with a shared housing, designed to mount to the rear subframe enabling a double isolated installation for best NVH. The X-Range C15 Direct Drive is designed as an ‘all-in-one’ powertrain to replace the rear electric drive unit of an existing BEV platform. It enables an automaker to use a single shared platform for their BEV, HEV, PHEV, and REEV lineups without any significant changes to vehicle design or production environments. The ne
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press release
CEO of Zhong, one of YouTube’s most-watched creators with 70 million subscribers and 95 million followers on all platforms, joins program The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press release
A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products.In their order, FDA concluded that: “Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals” The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom